Increased tumor expression of MMP-1, MMP-2, MMP-7, or MMP-9 in lung cancers [20-22], and increased expression of MMP-1 and MMP-9 in breast cancer [23,24] is associated with poor patient survival. This evidence concerns the gene MMP9 and breast carcinoma.